Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions
23 juin 2018 10h00 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press Release - No. 16/2018 Survey...
Zealand Pharma will attend the Jefferies Global Healthcare Conference on June 5-8, 2018 in New York
31 mai 2018 05h10 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release - No. 13 / 2018 ...
Zealand announces amendments to its Articles of Association following the granting of warrants
31 mai 2018 05h09 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 17/2018 ...
Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia
28 mai 2018 05h19 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company Announcement - No. 16/2018 ...
Zealand grants new warrants under employee warrant program
22 mai 2018 05h09 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 15/2018 ...
Zealand Pharma - Interim report for the first quarter of 2018
16 mai 2018 09h00 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 14 / 2018 ...
Zealand hosts conference call on May 16 at 4 pm CET/10 am EDT to present first quarter results 2018
14 mai 2018 06h56 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press Release - No. 12 / 2018 ...
Zealand Pharma to attend Deutsche Bank Securities 43rd Annual Health Care Conference, in Boston on May 8, 2018
02 mai 2018 06h27 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release - No 11 / 2018 ...
Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
27 avr. 2018 01h33 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 13/2018 ...
Zealand's Annual General Meeting in 2018
19 avr. 2018 11h15 HE
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 11 / 2018 ...